When most people think of cancer, names like breast, lung, or prostate cancer instantly come to mind. However, there’s ...

Despite its relative obscurity, this is one of the most aggressive and challenging cancers to diagnose and treat.

PURPOSETo assess the safety and efficacy of the third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor osimertinib as neoadjuvant therapy in patients with surgically ...